Quantitative evaluation of liver metastases density on computed tomography: A new tool to evaluate early response to bevacizumab-containing chemotherapy.


Medical Oncology Unit, Regional cancer institute of Montpellier(ICM)-Val d'Aurelle, Montpellier Cedex 5, France; IRCM, Inserm, University of Montpellier, ICM, Montpellier, France. Electronic address: [Email]


Response Evaluation Criteria in Solid Tumors (RECIST) are used to assess tumour shrinkage after cytotoxic chemotherapy, but may be inadequate for efficacy evaluation of anti-angiogenic therapies.


Bevacizumab,Contrast-enhanced computed tomography,Metastatic colorectal cancer,Tumour-to-liver density,